SEC 13F Intelligence

Falcon Point Capital, LLC / NEO

Falcon Point Capital, LLC’s Neogenomics Inc Position

Does Falcon Point Capital, LLC own Neogenomics Inc (NEO)? Not currently — the last reported position was 14.4K shares worth $446,000 in Q2 2020; the fund’s latest 13F (Q4 2020) no longer reports it.

Position Value
$446,000
Q2 2020
Shares
14.4K
% of Portfolio
+2.18%
Quarters Held
6
position exited

Position History NEO

Reported value by quarter
Q1 ’19: $5MQ1 ’19Q2 ’19: $5MQ2 ’19Q3 ’19: $5MQ3 ’19Q4 ’19: $2MQ4 ’19Q1 ’20: $2MQ1 ’20Q2 ’20: $446,000Q2 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202014.4K$446,000+2.18%
Q1 202071.1K$2M+4.26%
Q4 201982.8K$2M+3.08%
Q3 2019227.9K$5M+2.86%
Q2 2019218.3K$5M+2.58%
Q1 2019220.0K$5M+2.45%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Falcon Point Capital, LLC’s full portfolio or all institutional holders of NEO.